AGGIORNAMENTO EVENTO MOTORE SANITA’ “EQUITA’ DI ACCESSO ALL’INNOVAZIONE ” – CATANIA 10 LUGLIO 2024
Leggi
Incretin-based therapy and the risk of diabetic foot ulcers and related events
Werkman NCC, Driessen JHM, Klungel OH, et al.
Diabetes Obes Metab. Pub online 1 Jul 2024.
Leggi
Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies
Neeland IJ, Linge J, Birkenfeld AL
Diabetes Obes Metab. Pub online 27 Jun 2024.
Leggi
Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk with and without diabetes or previous stroke: an open-label, blinded-outcome, randomised trial
Liu J, Li Y, Ge J, et al. Lancet. Pub online 27 Jun 2024. https://doi.org/10.1016/S0140-6736(24)01028-6
Leggi
Once-weekly insulin icodec compared with daily basal insulin analogues in type 2 diabetes: participant-level meta-analysis of the ONWARDS 1-5 trials
Bajaj HS, Ásbjörnsdóttir B, Bari TJ, et al.
Diabetes Obes Metab. Pub online 1 Jul 2024.
Leggi
Glucagon-like peptide 1 receptor agonists and 13 obesity-associated cancers in patients with type 2 diabetes
Wang L, Xu R, Kaelber DC, Berger NA
JAMA Netw Open. Pub online 1 Jul 2024.
Leggi
Mechanisms underlying the development of eating disorders and disordered eating in adolescent females with type 1 diabetes
Abild CB, Vestergaard ET, Bruun JM, et al.
Diabet Med. Pub online 30 Jun 2024.
Leggi
Oral insulin delay of stage 3 type 1 diabetes Revisited in HLA DR4-DQ8 participants in the TrialNet oral insulin prevention trial (TN07)
v
Leggi
Major cardiovascular events and death in parents of children with type 1 diabetes: a register-based matched cohort study in Sweden
Kennedy B, Wernroth ML, Batra G, et al.
Diabetologia. Pub. online 26 Jun 2024.
Leggi